Buprenorphine And Naloxone Tablet
Product Images NDC 70518-3389

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 70518-3389). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Packaging label for Buprenorphine and Naloxone sublingual tablets, 8 mg/2 mg strength. The label indicates a package quantity of 30 tablets and displays the schedule classification as C-III. The product is labeled RX only and repackaged by RemedyRepack Inc. The original manufacturer is Rhodes Pharma, Coventry, RI.*

FDA Label Image

Chemical Structure (Buprenorphine 01)

Chemical structure of Buprenorphine and Naloxone showing the molecular framework including hydroxyl, methoxy, and other functional groups along with a hydrochloride (HCl) moiety. The image depicts the arrangement of atoms and bonds characteristic of this active ingredient used in sublingual tablets.*

FDA Label Image

Chemical Structure (Buprenorphine 02)

Chemical structure of Buprenorphine hydrochloride dihydrate, showing the molecular arrangement including hydroxyl, nitrogen, and carbonyl groups along with HCl and two water molecules as part of the hydrate form.*

FDA Label Image

Image (Buprenorphine 03)

An instructional illustration showing a person opening their mouth with a finger pressing a tablet under the tongue, demonstrating sublingual tablet administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.